FdaApplication
BLA 761108
Identifiers
- fda_app_no: BLA761108
Properties
| Property | Value |
|---|---|
| applicant_name | Alexion Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2018-12-21 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ULTOMIRIS | RAVULIZUMAB-CWVZ | 300MG/30ML (10MG/ML) | Injection |
| ULTOMIRIS | — | 300MG/3ML (100MG/ML) | Injection |
| ULTOMIRIS | — | 245MG/3.5ML (70MG/ML) | Injection |
| ULTOMIRIS | — | 1,100MG/11ML (100MG/ML) | Injection |
4 products